ArticleBritish journal of haematology2022
Managing argatroban in heparin-induced thrombocytopenia: A retrospective analysis of 729 treatment days in 32 patients with confirmed heparin-induced thrombocytopenia.
Article in British journal of haematology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
13 citing papers in PubMed, 15 citations in OpenAlex.
- Review of the Current Issues Surrounding Monitoring of the Direct Thrombin Inhibitor Argatroban in the Laboratory.International journal of laboratory hematology · 2026Review
- Evaluation of argatroban to warfarin transition process in heparin-induced thrombocytopenia.Journal of thrombosis and thrombolysis · 2026Article
- Comparative effectiveness of parenteral anticoagulants (fondaparinux, argatroban, bivalirudin) in heparin-induced thrombocytopenia: A systematic review.World journal of methodology · 2026Article
- Outcomes of patients with suspected heparin-induced thrombocytopenia in a contemporary multicenter cohort.Blood advances · 2025Article
- Pitfalls in Argatroban Monitoring: Heparin Interference With Dilute Thrombin Time Assays.International journal of laboratory hematology · 2025Article
- A new strategy for monitoring of direct oral anticoagulants in patients with cyanotic and complex congenital heart disease.International journal of cardiology. Congenital heart disease · 2024Article
- Detection of enoxaparin and argatroban by use of the novel viscoelastic coagulometer ClotPro.Scientific reports · 2024Article
- Proteomic profiling for biomarker discovery in heparin-induced thrombocytopenia.Blood advances · 2024Article
- Imaging and clinical outcomes of COVID-19- vs. non-COVID-19-related cerebral venous thrombosis.Frontiers in stroke · 2024Article
- Anticoagulants in adult extracorporeal membrane oxygenation: alternatives to standardized anticoagulation with unfractionated heparin.European journal of clinical pharmacology · 2023Review
- How to Solve the Conundrum of Heparin-Induced Thrombocytopenia during Cardiopulmonary Bypass.Journal of clinical medicine · 2023Review
- Combinations of rapid immunoassays for a speedy diagnosis of heparin-induced thrombocytopenia.Journal of thrombosis and haemostasis : JTH · 2022Article
- Managing argatroban in heparin-induced thrombocytopenia: A retrospective analysis of 729 treatment days in 32 patients with confirmed heparin-induced thrombocytopenia.British journal of haematology · 2022Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors at 2 institutions in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
PubMed holds no abstract for this paper.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.